Temporal gene expression in the hippocampus and peripheral organs to endotoxin-induced systemic inflammatory response in caspase-1-deficient mice

NeuroImmunoModulation

Volumn 22, Issue 4, 2015, Pages 263-273

  Mastronardi, Claudio Alberto ^a   Paz Filho, Gilberto ^a   Zanoni, Martina ^c   Molano González, Nicolas ^d   Arcos Burgos, Mauricio ^a   Licinio, Julio ^b   Wong, Ma Li ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Adamts1; Chemokines; Coexpression; Cox2; Cxcl1; Cxcl10; Inflammation; Lipopolysaccharide; Nos2; Transcription

Indexed keywords

ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE;

ADAMTS1 GENE; ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASPASE 1 GENE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CXC MOTIF LIGAND 1 GENE; CXC MOTIF LIGAND 10 GENE; DISINTEGRIN LIKE AND METALLOPEPTIDASE WITH THROMBOSPONDIN TYPE 1 MOTIF 1 GENE; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENE INTERACTION; GENETIC ASSOCIATION; GUANYLATE BINDING PROTEIN 2 GENE; HIPPOCAMPUS; IMMUNE RESPONSE GENE; IMMUNOGENETICS; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; INFLAMMATION; INJECTION; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; LETHALITY; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2 GENE; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T CELL SPECIFIC GTPASE 1 GENE; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ADRENAL GLANDS; ANIMALS; CASPASE 1; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HIPPOCAMPUS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84928418148     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000368310     Document Type: Article

References (51)

1. Takala A, Nupponen I, Kylanpaa-Back ML, Repo H: Markers of inflammation in sepsis. Ann Med 2002; 34: 614-623.
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150.
3. Wong ML, Xie B, Beatini N, Phu P, Marathe S, Johns A, Gold PW, Hirsch E, Williams KJ, LicinioI J, Tabas I: Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci U S A 2000; 97: 8681-8686.
4. Mastronardi CA, Srivastava V, Yu WH, Les Dees W, McCann SM: Lipopolysaccharideinduced leptin synthesis and release are differentially controlled by α-melanocytestimulating hormone. Neuroimmunomodulation 2005; 12: 182-188.
5. Mastronardi CA, Yu WH, McCann S: Lipopolysaccharide-induced tumor necrosis factor-α release is controlled by the central nervous system. Neuroimmunomodulation 2001; 9: 148-156.
6. Mastronardi CA, Yu WH, Rettori V, McCann S: Lipopolysaccharide-induced leptin release is not mediated by nitric oxide, but is blocked by dexamethasone. Neuroimmunomodulation 2000; 8: 91-97.
7. Wong ML, Bongiorno PB, Rettori V, McCann SM, Licinio J: Interleukin (IL) 1β, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc Natl Acad Sci U S A 1997; 94: 227-232.
8. Wong M-L, Rettori V, Al-Shekhlee A, Bongiorno PB, Canteros G, McCann SM, Gold PW, Licinio J: Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nature Med 1996; 2: 581-584.
9. Mastronardi CA, Yu WH, Srivastava VK, Dees WL, McCann SM: Lipopolysaccharide-induced leptin release is neurally controlled. Proc Natl Acad Sci U S A 2001; 98: 14720-14725.
10. Wong ML, O'Kirwan F, Khan N, Hannestad J, Wu KH, Elashoff D, Lawson G, Gold PW, McCann SM, Licinio J: Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis. Proc Natl Acad Sci U S A 2003; 100: 14241-14246.
11. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeldet J, et al: Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995; 80: 401-411.
12. Mastronardi C, Whelan F, Yildiz OA, Hannestad J, Elashoff D, McCann SM, Licinio J, Wong ML: Caspase 1 deficiency reduces inflammation-induced brain transcription. Proc Natl Acad Sci U S A 2007; 104: 7205-7210.
13. Chesnokova V, Melmed S: Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 2002; 143: 1571-1574.
14. Carnio EC, Moreto V, Giusti-Paiva A, Antunes-Rodrigues J: Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release. Endocr Metab Immune Disord Drug Targets 2006; 6: 137-142.
15. Chrousos GP: The hypothalamic-pituitaryadrenal axis and immune-mediated inflammation. New Engl J Med 1995; 332: 1351-1362.
16. Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117: 289-296.
17. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19: 269-301.
18. Schobitz B, Sutanto W, Carey MP, Holsboer F, de Kloet ER: Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 1994; 60: 124-133.
19. Bener D, Wohlman A, Itzik A, Yirmiya R, Ben-Hur T, Weidenfeld J: Glucocorticoid resistance following herpes simplex-1 infection: role of hippocampal glucocorticoid receptors. Neuroendocrinology 2007; 85: 207-215.
20. Yao JH, Ye SM, Burgess W, Zachary JF, Kelley KW, Johnson RW: Mice deficient in interleukin-1β converting enzyme resist anorexia induced by central lipopolysaccharide. Am J Physiol 1999; 277:R1435-R1443.
21. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289-300.
22. Suzuki R, Shimodaira H: Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 2006; 22: 1540-1542.
23. Mastronardi CA, Licinio J, Wong ML: Candidate biomarkers for systemic inflammatory response syndrome and inflammation: a pathway for novel translational therapeutics. Neuroimmunomodulation 2010; 17: 359-368.
24. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182: 591-595.
25. Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF: NG-methyl-L-arginine inhibits tumor necrosis factorinduced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A 1990; 87: 3629-3632.
26. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557-1558.
27. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34-39.
28. Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, Bruining HA: Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med 1998; 26: 660-667.
29. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32: 21-30.
30. Kinasewitz GT, Privalle CT, Imm A, Steingrub JS, Malcynski JT, Balk RA, DeAngelo J: Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock. Crit Care Med 2008; 36: 1999-2007.
31. Aronoff DM: Cyclooxygenase inhibition in sepsis: is there life after death? Mediators Inflamm 2012; 2012: 696897.
32. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB: The effects of ibuprofen on the physiology and survival of patients with sepsis. New Engl J Med 1997; 336: 912-918.
33. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB: Effect of ibuprofen in patients with severe sepsis: a randomized, doubleblind, multicenter study. The Ibuprofen Study Group. Crit Care Med 1991; 19: 1339-1347.
34. Memis D, Karamanlioglu B, Turan A, Koyuncu O, Pamukcu Z: Effects of lornoxicam on the physiology of severe sepsis. Crit Care 2004; 8:R474-R482.
35. Arons MM, Wheeler AP, Bernard GR, Christman BW, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson W, Wright P, Dupont WD, Swindell BB: Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 1999; 27: 699-707.
36. Hirsch E, Irikura VM, Paul SM, Hirsh D: Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A 1996; 93: 11008-11013.
37. Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 1997; 25: 1115-1124.
38. Fisher CJ Jr, Opal SM, Lowry SF, Sadoff JC, LaBrecque JF, Donovan HC, Lookabaugh JL, Lemke J, Pribble JP, Stromattet SC, et al: Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. Circ Shock 1994; 44: 1-8.
39. Puneet P, Moochhala S, Bhatia M: Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005; 288: L3-L15.
40. Oynebraten I, Bakke O, Brandtzaeg P, Johansen FE, Haraldsen G: Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood 2004; 104: 314-320.
41. Carlow DA, Teh SJ, Teh HS: Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases. J Immunol 1998; 161: 2348-2355.
42. Carlow DA, Marth J, Clark-Lewis I, Teh HS: Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif. J Immunol 1995; 154: 1724-1734.
43. Lafuse WP, Brown D, Castle L, Zwilling BS: Cloning and characterization of a novel cDNA that is IFN-γ-induced in mouse peritoneal macrophages and encodes a putative GTPbinding protein. J Leukoc Biol 1995; 57: 477-483.
44. MacMicking JD: IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 2004; 25: 601-609.
45. Pilla DM, Hagar JA, Haldar AK, Mason AK, Degrandi D, Pfeffer K, Ernst RK, Yamamoto M, Miao EA, Coers J: Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. Proc Natl Acad Sci U S A 2014; 111: 6046-6051.
46. Shindo T, Kurihara H, Kuno K, Yokoyama H, Wada T, Kurihara Y, Imai T, Wang Y, Ogata M, Nishimatsu H, Moriyama N, Oh-hashi Y, Morita H, Ishikawa T, Nagai R, Yazaki Y, Matsushima K: ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest 2000; 105: 1345-1352.
47. Oveland E, Karlsen TV, Haslene-Hox H, Semaeva E, Janaczyk B, Tenstad O, Wiig H: Proteomic evaluation of inflammatory proteins in rat spleen interstitial fluid and lymph during LPS-induced systemic inflammation reveals increased levels of ADAMST1. J Proteome Res 2012; 11: 5338-5349.
48. Howell MD, Torres-Collado AX, Iruela-Arispe ML, Gottschall PE: Selective decline of synaptic protein levels in the frontal cortex of female mice deficient in the extracellular metalloproteinase ADAMTS1. PLoS One 2012; 7: e47226.
49. Lee JH, Jung HS, Giang PM, Jin X, Lee S, Son PT, Lee D, Hong YS, Lee K, Lee JJ: Blockade of nuclear factor-κB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera . J Pharmacol Exp Ther 2006; 316: 271-278.
50. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM: Non-canonical inflammasome activation targets caspase-11. Nature 2011; 479: 117-121.
51. Vanden Berghe T, Demon D, Bogaert P, Vandendriessche B, Goethals A, Depuydt B, Vuylsteke M, Roelandt R, Van Wonterghem E, Vandenbroecke J, Choi SM, Meyer E, Krautwald S, Declercq W, Takahashi N, Cauwels A, Vandenabeele P: Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med 2014; 189: 282-291.